Volume | 895,051 |
|
|||||
News | - | ||||||
Day High | 2.64 | Low High |
|||||
Day Low | 2.455 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Organogenesis Holdings Inc | ORGO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
2.48 | 2.455 | 2.64 | 2.50 | 2.49 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
6,541 | 895,051 | US$ 2.55 | US$ 2,281,388 | - | 1.91 - 4.705 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
17:23:47 | 24 | US$ 2.46 | USD |
Organogenesis Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
329.91M | 131.96M | - | 433.14M | 4.95M | 0.04 | 66.67 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Organogenesis News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ORGO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.29 | 2.92 | 2.26 | 2.46 | 1,134,524 | 0.21 | 9.17% |
1 Month | 2.78 | 3.065 | 2.165 | 2.75 | 1,381,446 | -0.28 | -10.07% |
3 Months | 3.64 | 3.86 | 2.165 | 2.89 | 918,841 | -1.14 | -31.32% |
6 Months | 2.39 | 4.705 | 1.96 | 3.00 | 949,508 | 0.11 | 4.60% |
1 Year | 1.93 | 4.705 | 1.91 | 3.09 | 945,351 | 0.57 | 29.53% |
3 Years | 23.69 | 23.99 | 1.795 | 6.63 | 1,018,322 | -21.19 | -89.45% |
5 Years | 7.85 | 24.3363 | 1.795 | 7.14 | 719,010 | -5.35 | -68.15% |
Organogenesis Description
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. |